Zubair Qureshi
- Molecular Medicine top 0.2%
- Pharmacology top 2%
- Epidemiology top 10%
- Endocrinology top 1%
- Applied Microbiology and Biotechnology top 0.5%
- Co-authors
- Yohei DoiDavid L. PatersonJennifer Adams‐HaduchBrian A. PotoskiBruce PolskyEmilia Mia SordilloAlveena SyedRyan K. Shields
- Topics
- Antibiotic Resistance in Bacteria (11 papers)Antibiotics Pharmacokinetics and Efficacy (7 papers)Escherichia coli research studies (4 papers)
- Journals
- SHILAP Revista de lepidopterologíaClinical Infectious DiseasesAntimicrobial Agents and Chemotherapy
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Zubair Qureshi
21 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Molecular Medicine 1.1k
- Pharmacology 512
- Epidemiology 388
- Endocrinology 330
- Applied Microbiology and Biotechnology 259
Countries citing papers authored by Zubair Qureshi
This map shows the geographic impact of Zubair Qureshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zubair Qureshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zubair Qureshi more than expected).
Fields of papers citing papers by Zubair Qureshi
This network shows the impact of papers produced by Zubair Qureshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zubair Qureshi. The network helps show where Zubair Qureshi may publish in the future.
Co-authorship network of co-authors of Zubair Qureshi
This figure shows the co-authorship network connecting the top 25 collaborators of Zubair Qureshi. A scholar is included among the top collaborators of Zubair Qureshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zubair Qureshi. Zubair Qureshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 1 | |
| 4 | 313 | |
| 5 | 17 | |
| 6 | 27 | |
| 7 | 22 | |
| 8 | 13 | |
| 9 | Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimensbreakdown → | 438 |
| 10 | 42 | |
| 11 | 36 | |
| 12 | 34 | |
| 13 | 56 | |
| 14 | 36 | |
| 15 | 115 | |
| 16 | 44 | |
| 17 | 69 | |
| 18 | 55 | |
| 19 | GPs' attitudes to benzodiazepine and 'Z-drug' prescribing: a barrier to implementation of evidence and guidance on hypnotics. | 90 |
| 20 | 12 |
About Zubair Qureshi
Zubair Qureshi is a scholar working on Molecular Medicine, Endocrinology and Applied Microbiology and Biotechnology, having authored 21 papers that have together received 1.4k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (11 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Escherichia coli research studies (4 papers). The work is most often cited by research in Molecular Medicine (1.1k citations), Applied Microbiology and Biotechnology (259 citations) and Endocrinology (330 citations). Zubair Qureshi has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Yohei Doi, David L. Paterson, Jennifer Adams‐Haduch, Brian A. Potoski, Bruce Polsky, Emilia Mia Sordillo, Alveena Syed, Ryan K. Shields, A. William Pasculle and Lauren Hittle. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.